Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1976 Mar;13(3):949-58.
doi: 10.1128/iai.13.3.949-958.1976.

Immune mechanism in Pasteurella multocida-infected mice

Comparative Study

Immune mechanism in Pasteurella multocida-infected mice

J B Woolcock et al. Infect Immun. 1976 Mar.

Abstract

Various immunizing procedures were tested for their effect on the growth of Pasteurella multocida in specific pathogen-free CD-1 mice. Two injections with killed vaccine incorporated into Freund complete adjuvant gave excellent protection against parenteral challenge, but less to control the growth of an aerogenic inoculum. Protection with adjuvant-treated preparation was always superior to that seen with non-adjuvant-treated vaccines. A killed saline-suspended vaccine introduced aerogenically marginally increased resistance to small (2 to 5 mean lethal doses) aerogenic challenges. Live mycobacterium bovis (BCG) vaccine immunopotentiated a single dose of heat-killed P. multocida vaccine in terms of the protective immune response against a subsequent footpad challenge. Hyperimmune mouse serum, administered intraperitoneally, intramuscularly, or intravenously 1 to 7 days prior to subcutaneous challenge with 500 to 5,000 P. multocida, was highly protective. Mice injected in the thigh with 0.2 ml of hyperimmune serum prior to footpad challenge frequently developed a severe inflammatory response with local swelling within 48 h; these lesions often became severly abscessed with time. The passively protected, footpad-infected mice developed active immunity against a subsequent challenge given into the opposite footpad.

PubMed Disclaimer

References

    1. Am Rev Respir Dis. 1975 Jan;111(1):43-51 - PubMed
    1. J Immunol. 1973 Aug;111(2):358-68 - PubMed
    1. Can J Comp Med. 1972 Apr;36(2):129-37 - PubMed
    1. J Infect Dis. 1972 Jul;126(1):69-76 - PubMed
    1. J Natl Cancer Inst. 1973 Nov;51(5):1669-76 - PubMed

Publication types

MeSH terms

LinkOut - more resources